NEW BRUNSWICK, N.J. - Johnson & Johnson will take an 18.4 percent stake in Ireland-based drug developer Elan Corp. with a $1 billion investment.

NEW BRUNSWICK, N.J. - Johnson & Johnson will take an 18.4 percent stake in Ireland-based drug developer Elan Corp. with a $1 billion investment.